JP4781621B2 - Cxcr4拮抗薬およびその用途 - Google Patents

Cxcr4拮抗薬およびその用途 Download PDF

Info

Publication number
JP4781621B2
JP4781621B2 JP2003301176A JP2003301176A JP4781621B2 JP 4781621 B2 JP4781621 B2 JP 4781621B2 JP 2003301176 A JP2003301176 A JP 2003301176A JP 2003301176 A JP2003301176 A JP 2003301176A JP 4781621 B2 JP4781621 B2 JP 4781621B2
Authority
JP
Japan
Prior art keywords
arg
cys
tyr
cit
nal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2003301176A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004107333A (ja
JP2004107333A5 (cg-RX-API-DMAC7.html
Inventor
信孝 藤井
啓和 玉村
晃 堀
Original Assignee
バイオカイン セラピューティックス リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バイオカイン セラピューティックス リミテッド filed Critical バイオカイン セラピューティックス リミテッド
Priority to JP2003301176A priority Critical patent/JP4781621B2/ja
Publication of JP2004107333A publication Critical patent/JP2004107333A/ja
Publication of JP2004107333A5 publication Critical patent/JP2004107333A5/ja
Application granted granted Critical
Publication of JP4781621B2 publication Critical patent/JP4781621B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP2003301176A 2002-08-27 2003-08-26 Cxcr4拮抗薬およびその用途 Expired - Fee Related JP4781621B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2003301176A JP4781621B2 (ja) 2002-08-27 2003-08-26 Cxcr4拮抗薬およびその用途

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002247843 2002-08-27
JP2002247843 2002-08-27
JP2003301176A JP4781621B2 (ja) 2002-08-27 2003-08-26 Cxcr4拮抗薬およびその用途

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011060367A Division JP5315372B2 (ja) 2002-08-27 2011-03-18 Cxcr4拮抗薬およびその用途

Publications (3)

Publication Number Publication Date
JP2004107333A JP2004107333A (ja) 2004-04-08
JP2004107333A5 JP2004107333A5 (cg-RX-API-DMAC7.html) 2006-09-14
JP4781621B2 true JP4781621B2 (ja) 2011-09-28

Family

ID=32301222

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003301176A Expired - Fee Related JP4781621B2 (ja) 2002-08-27 2003-08-26 Cxcr4拮抗薬およびその用途

Country Status (1)

Country Link
JP (1) JP4781621B2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105163749B (zh) * 2013-03-24 2018-03-27 拜欧肯治疗有限公司 治疗骨髓性白血病的方法
MX2017016844A (es) 2015-07-16 2018-08-15 Biokine Therapeutics Ltd Composiciones y procedimientos para tratar cancer.
CA3014530A1 (en) 2016-02-23 2017-08-31 Biolinerx Ltd. Methods of treating acute myeloid leukemia
BR112021008797A2 (pt) * 2018-11-09 2021-08-31 Neopep Pharma Gmbh & Co. Kg Polipeptídeos para o tratamento de síndromes de estresse, imunorreação e derrame

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69416824T2 (de) * 1993-10-14 1999-07-08 Seikagaku Corp., Tokio/Tokyo Polypeptide und daraus hergestellte, gegen hiv wirksame substanzen
DE69914463T2 (de) * 1998-03-13 2004-11-11 The University Of British Columbia, Vancouver Therapeutische chemokine rezeptor antagonisten
CA2389979C (en) * 1999-11-24 2011-08-16 Schering Corporation Methods of inhibiting metastasis
DE60103052T2 (de) * 2000-05-09 2005-03-03 The University Of British Columbia, Vancouver Verwendung von cxcr4 antagonisten zur behandlung von krebs und autoimmunkrankheiten
EP1323730B1 (en) * 2000-09-05 2010-04-21 Biokine Therapeutics Ltd. Novel polypeptides and anti-hiv drugs containing the same

Also Published As

Publication number Publication date
JP2004107333A (ja) 2004-04-08

Similar Documents

Publication Publication Date Title
JP5315372B2 (ja) Cxcr4拮抗薬およびその用途
JP2022551153A (ja) 活性ポリペプチド化合物
BRPI0717441B1 (pt) Composto, medicamento, e, uso do derivado de metastina
ES2375038T3 (es) Derivados de metastina y su uso.
JP2010500298A (ja) 癌のような変更された細胞遊走に関連する障害の治療のための薬理学的活性を有するペプチド
HRP960257A2 (en) New compounds, their preparation and use
JP2016065018A (ja) Cxcr7結合剤およびcxcr7結合剤を含有する医薬組成物
KR100286242B1 (ko) 돌라스타틴 유도체
BG65926B1 (bg) Кахалалидни съединения
PL180372B1 (pl) Peptyd bedacy antagonista bombezyny oraz kompozycja farmaceutyczna zawierajaca ten peptyd PL PL PL PL PL PL
CN113024635B (zh) 一类订书肽化合物及其药物组合物的用途
KR20220110789A (ko) 칼슘 감지 수용체 효능제 화합물 및 이의 응용
JP6952320B2 (ja) 新規nk3受容体アゴニスト
JP2012509312A (ja) 腫瘍壊死因子α阻害ペプチドおよびその使用方法
JP5698977B2 (ja) メタスチン誘導体およびその用途
JP2001518515A (ja) リウマチ性関節炎の治療組成物および治療方法
JP2004107333A (ja) Cxcr4拮抗薬およびその用途
WO2006041205A1 (ja) 血管形成促進剤
JP4160505B2 (ja) 自己免疫疾患の治療の構想における翻訳後型修飾を含むペプチドの使用
CA2405724C (en) Substance p analogs for the treatment of cancer
JP2004196769A (ja) 新規cxcr4アンタゴニスト
IE903958A1 (en) Reduced irreversible bombesin antagonists
KR20160034943A (ko) 바소프레신-2 수용체 작용제
WO2014061772A1 (ja) 新規nk3受容体アゴニスト
HRP960585A2 (en) Novel peptides, their preparation and use

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20050222

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20050222

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20050222

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20051118

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060728

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060728

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20090811

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091111

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091116

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20091210

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20091215

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100108

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20101019

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110113

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110118

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110217

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110222

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110318

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110517

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110523

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110610

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110706

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20140715

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 4781621

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees